SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (311)3/29/2004 1:23:18 PM
From: Jim Oravetz  Read Replies (1) of 370
 
Vion Pharmaceuticals Registers 17.2M Shares For Holders
DOW JONES NEWSWIRES
March 29, 2004 12:12 p.m.

WASHINGTON -- Vion Pharmaceuticals Inc. (VION) registered
about 17.2 million shares for certain shareholders who may sell the shares from
time to time.
The number of shares being offered includes 3,688,463 shares which
are issuable upon the exercise of warrants, according to a registration
statement filed Monday with the Securities and Exchange Commission.
Vion Pharmaceuticals said it won't receive any proceeds from the sale
of the shares other than the exercise price payable upon the exercise of the
warrants.
Vion said it issued the shares and warrants to the selling
stockholders in a private transaction.
Vion, based in New Haven, Conn., develops therapeutics and
technologies for the treatment of cancer.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News